| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 19.3 | 8.6 |
| Profit before tax | -8.1 | -19.6 |
| Net income | -8.1 | -19.6 |
| EPS (diluted, $ a share) | $-0.08 | $-0.22 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +124.0% |
|---|---|
| Operating margin | -38.6% |
10-Q filed with the SEC, NASDAQ: CDXS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Codexis, Inc.: key numbers
- Share price
- $1.06Close, Nov 16
- Market cap
- $116M
- Shares outstanding
- 109.6MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Industrial Organic ChemicalsSIC 2860
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Codexis, Inc.
All →Codexis Earnings Call: Key Takeaways
Codexis reported strong Q3 2026 revenue growth driven by biocatalysis and significant technical milestones in its Ecosynthesis platform, including 100-gram scale production and improved potency.
- Call
- Nov 12, 2026, 4:30 PM ET
Codexis Financial Results
Codexis reported Q3 2026 revenue of $19.3 million, a significant increase from $8.6 million in the prior year, driven by higher product revenue from new customer launches. The company also highlighted a new $60 million term loan facility with Trinity Capital and the successful scale-up of its ECO Synthesis Manufacturing Platform to 100-gram scale.
- Term
- Q3 2026
“I am pleased with our outstanding progress in 2026, through both innovation and technical achievements, that has garnered attention from leading innovators in the siRNA field.”
Alison Moore, PhD, President and Chief Executive Officer
“We have made significant progress in industrializing our technology while simultaneously increasing our revenue base, managing expenses, and improving the financial stability of our company.”
Alison Moore, PhD, President and Chief Executive Officer
Codexis $60M Debt Financing with Trinity Capital Inc.
Codexis entered into a $60 million Loan and Security Agreement with Trinity Capital, consisting of a $42.5 million initial tranche and $17.5 million in subsequent tranches. The debt is secured by substantially all company assets and carries a variable interest rate with an interest-only period extending up to November 2030. The facility provides capital to support operations while maintaining a financial covenant tied to the company's market capitalization.
- Value
- $60M
- Counterparty
- Trinity Capital Inc.
- Term
- 5 years